Novavax’s Upcoming Eventful Q2
Research - Novavax (NVAX) has been one of the companies most affected by the March biotech decline. It is now trading under $200/share, near levels where it … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Expectations Ahead of AACR 2021
Insights - The American Association for Cancer Research (AACR) annual meeting will be hosted this coming weekend (April 9-14). Below is data to look for that will … Continue Reading
Premium
9Meters Announces Financing Amid Biotech Rout
Insights - 9Meters (NMTR) announced a $30M raise this morning, selling 30M shares at $1/share. After this deal, fully diluted share count is approximately 297M. At a … Continue Reading
Premium
Is Delcath’s Phase 3 Data Enough For The FDA?
Research - Delcath (DCTH) released preliminary data for their Phase 3 in metastatic ocular melanoma (mOM). The preliminary analysis included 79 of 91 (87%) treated patients. Final results on … Continue Reading
Premium9Meter’s NM-002 Showing Early Signs of PS Reduction
Insights - 9Meters (NMTR) had their KOL call to give an update on the NM-002 program for short bowel syndrome (SBS). Yesterday, NMTR also announced that their interim Phase 3 … Continue Reading
Premium
Expectations for MGTA-145 in Mobilizing Myeloma Patients for Transplant
Insights - Magenta presented data for their mobilizing agent MGTA-145 at the European Society for Blood and Marrow Transplantation (EBMT 2021). The data was not new, but it gave … Continue Reading
Premium9Meters Has a Novel MoA for SBS That Could Be Worth Billions
Research - 9 Meters (NMTR) is developing a novel treatment for short bowel syndrome (“SBS”) by focusing on slowing food transit time through the gastrointestinal (“GI”) tract. … Continue Reading
Premium